Lundbeckfond Invest A/S → IO Biotech, Inc. IOBTQ

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 16/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%

Passive Schedule 13G filer baseline
Elevated short days-to-cover (34.0 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-10-15

DTC 34.02

470,505 shares short · 0.0% vs prior

Other 13D/G Filings on IO Biotech, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-02	SCHEDULE 13D/A	Lundbeckfond Invest A/S	27.40%	21,851,920	view →
2026-01-23	SCHEDULE	Novo Holdings A/S	3.30%	2,469,135	view →
2023-08-11	SC	Novo Holdings A/S	—	—	view →

Other Filings by Lundbeckfond Invest A/S

Filed	Form	Issuer	Stake	Shares
2026-06-02	SCHEDULE 13D/A	IO Biotech, Inc. IOBTQ	27.40%	21,851,920	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →